The study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).

The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” ...

GSK has announced a partnership with the UK Dementia Research Institute and Health Data Research UK to explore a potential ...

The UK government is providing £2 million ($2.6 million) in funding to allow digital assessment to be added to a ...

GSK said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its ...

Prominent outside scientists who help the NIH evaluate its internal research programs are being abruptly removed ...

GSK, led by boss Emma Walmsley (pictured), is using the data of 1.4m adults aged 65 and 66 to examine the impact of its ...

UK pharma major GSK (LSE: GSK) today announced a major new research collaboration with the UK Dementia Research Institute (UK ...

At present, Shingrix is used to prevent herpes zoster (shingles), a painful skin rash caused by the varicella-zoster virus.

As Rachel Reeves launches into her latest fiscal update today, she may find solace in the adage that 'the darkest hour is just before dawn'.